1010 related articles for article (PubMed ID: 28002165)
21. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
23. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
[TBL] [Abstract][Full Text] [Related]
24. NT-proBNP incorporated in prediction rule of major peri-operative adverse cardiac event in non-cardiac surgery.
Binh TQ; Trang DV; Vuong NL; Khoi NV; Elfaituri MK; Huu Loc TT; Kamel MG; Minh LHN; Huy NT
Surgeon; 2019 Jun; 17(3):127-132. PubMed ID: 31003870
[TBL] [Abstract][Full Text] [Related]
25. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients.
Brynildsen J; Petäjä L; Pettilä V; Nygård S; Vaara ST; Linko R; Okkonen M; Hagve TA; Soininen L; Suojaranta-Ylinen R; Lyngbakken MN; Omland T; Røsjø H
Clin Biochem; 2018 Mar; 53():65-71. PubMed ID: 29371002
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
Ki YJ; Park S; Ha SI; Choi DH; Song H
Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
[TBL] [Abstract][Full Text] [Related]
27. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
29. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
30. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
[TBL] [Abstract][Full Text] [Related]
31. Rapid rule out of acute myocardial infarction in the observe zone using a combination of presentation N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin I.
Wang Y; Dai L; Wang N; Zhu Y; Chen M; Wang H
Clin Biochem; 2019 Aug; 70():34-38. PubMed ID: 31173734
[TBL] [Abstract][Full Text] [Related]
32. Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery.
Farzi S; Stojakovic T; Marko T; Sankin C; Rehak P; Gumpert R; Baumann A; Höfler B; Metzler H; Mahla E
Br J Anaesth; 2013 Apr; 110(4):554-60. PubMed ID: 23248094
[TBL] [Abstract][Full Text] [Related]
33. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
34. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
35. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
Apple FS; Murakami MM; Pearce LA; Herzog CA
Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
[TBL] [Abstract][Full Text] [Related]
37. Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
Echeverría LE; Rojas LZ; Calvo LS; Roa ZM; Rueda-Ochoa OL; Morillo CA; Muka T; Franco OH
Int J Cardiol; 2017 Jan; 227():577-582. PubMed ID: 27839809
[TBL] [Abstract][Full Text] [Related]
38. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
[TBL] [Abstract][Full Text] [Related]
39. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G
Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614
[TBL] [Abstract][Full Text] [Related]
40. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction.
Tiller C; Reindl M; Holzknecht M; Klapfer M; Beck A; Henninger B; Mayr A; Klug G; Reinstadler SJ; Metzler B
Eur J Intern Med; 2019 Jun; 64():57-62. PubMed ID: 30878297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
